The results of DolPHIN-1 are summarized: dolutegravir is better than efavirenz cures HIV in women at the extreme stages of pregnancy
#Dolutegravir demonstrated greater efficacy in suppressing HIV than efavirenz in late pregnancy, Dr. Saye Hu said at the 22nd International AIDS Conference (AIDS2018). According to him, the results of the DolPHIN-1 study showed that in pregnant women of HIV-positive women ...